Streptococcus Pyogenes and Acute Rheumatic Fever: How Strong are the Links in the Chain?

This narrative review synthesizes nearly two centuries of evidence linking Streptococcus pyogenes infection to acute rheumatic fever (ARF), the prerequisite for the development of rheumatic heart disease (RHD). Using the Bradford Hill criteria for causality and the Oxford Centre for Evidence-Based Medicine levels of evidence, we critically evaluate historical and contemporary data pertaining to this relationship. Strong evidence demonstrates that untreated S. pyogenes infection increases ARF incidence, while antibiotic treatment reduces incidence across diverse populations and settings. Moderate evidence supports the temporal sequence from infection to ARF and the exclusivity of S. pyogenes as ARF's causal precursor. Weaker but biologically coherent data suggest an underlying mechanism consistent with post-infectious autoimmune disease. Although foundational evidence is robust, key gaps remain, particularly the need for contemporary prospective data in high-risk populations and clarity on the contribution of skin infections. Strengthening this evidence base is essential as S. pyogenes vaccines advance toward licensure and ARF-specific policy indications.